Genetic and epigenetic changes in stomach cancer

International Review of Cytology

Volumn 204, Issue , 2001, Pages 49-95

  Yokozaki, H ^a   Yasui, W ^a   Tahara, E ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Epigenetic alteration; Gastric cancer; Genetic alteration; Human carcinogenesis

Indexed keywords

APC PROTEIN; CATENIN; CYCLIN E; PROTEASOME; PROTEIN P27; PROTEIN P53; SCATTER FACTOR; TELOMERASE;

CANCER GENETICS; CANCER GROWTH; GENE AMPLIFICATION; GENE INACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; METHYLATION; MICROSATELLITE INSTABILITY; ONCOGENE C ERB; ONCOGENE K RAS; PRIORITY JOURNAL; REVIEW; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0035124351     PISSN: 00747696     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7696(01)04003-7     Document Type: Article

References (268)

1. Clues to the pathogenesis of familial colorectal cancer
2. Expression of amphiregulin in human gastric cancer cell lines
3. Inhibition of cell growth by transforming growth factor β1 is associated with p53-independent induction of p21 in gastric carcinoma cells
4. Frequent amplification of the cyclin E gene in human gastric carcinomas
5. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines
6. SDI1/WAF1/CIP1/MDA6 gene in human gastric carcinomas
7. Human telomerase RNA and telomerase activity in immortal cell lines and tissues
8. Loss of heterozygosity at the bcl-2 gene locus and expression of bcl-2 in human gastric and colorectal carcinomas
9. Regulation mechanisms for the heterodimeric transcription factor, PEBP2/CBF
10. Loss of FHIT expression in gastric carcinoma
11. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas
12. Vascular permeability gene is expressed differentially in a normal tissues, macrophages, and tumors
13. Genetic predisposition to gastric cancer
14. A mutant p21 cyclin-dependent kinase inhibitor isolated from a Burkitt's lymphoma
15. A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer
16. Identification of the hepatocyte growth factor receptor as the c-met protoncogene product
17. Crystal structure and mutational analysis of the human CDK2 kinase complex with cell cycle-regulatory protein CksHs1
18. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer
19. Telomere elongation in immortal human cells without detectable telomerase activity
20. Expression and amplification of cyclin genes in human breast cancer
21. Mutations of mitotic checkpoint genes in human cancers
22. Oncogenes and signal transduction
23. MUC1 gene polymorphism and gastric cancer - An epidemiological study
24. Kip1 protein: Prognostic implications in primary breast cancer
25. The complex CD44 transcriptional unit; alternative splicing of three internal exons generates the epithelial form of CD44
26. Regulation of telomere length and function by a Myb-domain protein in fission yeast
27. The new era of cancer epidemiology
28. Human gastric carcinogenesis: A multistep and multifactorial process
29. Helicobacter pylori and gastric carcinogenesis
30. Growth factors in development, transformation, and tumorigenesis
31. Human telomeres are attached to the nuclear matrix
32. Biology of interleukin 1
33. The regulation of E2F by pRb-family proteins
34. WAF1, a potential mediator of p53 tumor suppression
35. Deletion mapping on chromosome 1p in well-differentiated gastric cancer
36. Loss of heterozygosity and loss of expresion of DCC gene in gastric cancer
37. Identification of a chromosome 18q gene that is altered in colorectal cancers
38. weel mitotic inhibitor is a tyrosine/serine kinase
39. The RNA component of human telomerase
40. Critical factors in the biology of human cancer metastasis: Twenty-eighth GHA Clowes memorial award lecture
41. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
42. A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase
43. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability
44. DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesis
45. CDC25 phosphatases as potential human oncogenes
46. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin
47. FHIT mutations in human primary gastric cancer
48. Partnership between DPC4 and SMAD proteins in TGF-β signaling pathways
49. Structural characterization and biological functions of fibroblast growth factor
50. E-cadherin germline mutations in familial gastric cancer
51. + gene, encodes a subunit of the Cdc28 protein kinase complex
52. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
53. Altered microsatellites in incomplete-type intestinal metaplasia adjacent to primary gastric cancers
54. Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer
55. Survival of patients with stomach cancer: Results from population-based cancer registrations
56. INK4b is a potent effector of TGF-β-induced cell cycle arrest
57. Telomere shortening during aging
58. The p21 Cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases
59. A mammalian telomerase-associated protein
60. Chemical and physical carcinogenesis: Advances and perspectives for the 1990s
61. K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes
62. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps
63. Evaluation of CD44 transcription variants in human digestive tract carcinomas and normal tissues
64. + encodes a predicted 13-kilodalton protein that is essential for cell viability and is directly involved in the division cycle of Schizosaccharomyces pombe
65. Telomerase activity in gastric cancer
66. In situ mRNA hybridization technique for analysis of human telomerase RNA in gastric precancerous and cancerous lesions
67. The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway
68. Frequent mutation of the p53 gene in human esophageal cancer
69. Regulation of telomerase activity in immortal cell lines
70. Refining the telomere-telomerase hypothesis of aging and cancer
71. cdc2 kinase on both Thr-14 and Tyr-15 by human cdc25B phosphatase
72. Frequent replication errors at microsatellite loci in tumors of patients with multiple primary cancers
73. Cooperation between oncogenes
74. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
75. Mutation frequency of the p16/CDKN2 gene in primary cancers in the upper digestive tract
76. Infrequent germ-line mutation of the E-cadherin gene in Japanese familial gastric cancer kindreds
77. Close correlation between mutations of E2F4 and hMSH3 genes in colorectal cancers with microsatellite instability
78. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis
79. Growth inhibition of transforming growth factor β on human gastric carcinoma cells: Receptor and postreceptor signaling
80. Reduced levels of transforming growth factor-beta type I receptor in human gastric carcinomas
81. Interleukin 1α acts as autocrine growth stimulator for human gastric carcinoma cells
82. Expression of interleukin-6 and its effect on the cell growth of gastric carcinoma cell lines
83. Hyperplasia of stomach epithelial cells of mice lacking PEBP2αC: Possible relation of the gene to human stomach cancer
84. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain
85. Japanese classification of gastric carcinoma, 2nd English edition
86. Cdc25A is a novel phosphatase functioning early in the cell cycle
87. p73 is a human p53-related protein that can induce apoptosis
88. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers
89. A cell cycle regulator potentially involved in genesis of many tumor types
90. ERBB2 expression and the gene amplification
91. K-sam gene encodes secreted as well as transmembrane receptor tyrosine kinase
92. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies
93. Cyclin E, a potential prognostic marker for breast cancer
94. Accumulated frameshift mutations at coding nucleotide repeats during the progression of gastric carcinoma with microsatellite instability
95. Specific association of human telomerase activity with immortal cells and cancer
96. Molecular mechanisms of loss of TGF-β signaling in human gastric cancer
97. Identification of FAP locus genes from chromosome 5q21
98. GC factor represses transcription of several growth factor/receptor genes and causes growth inhibition of human gastric carcinoma cell lines
99. Expression of amphiregulin, a novel gene of the epidermal growth factor family, in human gastric carcinomas
100. Regulation of angiogenesis in human gastric carcinomas by interleukin-8
101. Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas
102. Mutation and cancer: Statistical study of retinoblastoma
103. Interleukin-8 as a macrophage-derived mediator of angiogenesis
104. The crystal structure of the DNA-binding domain of yeast PAPI in complex with telomeric DNA
105. Expression of a cell cycle regulator CKshs I in human gastrointestinal carcinomas
106. Overexpression of cyclin-dependent kinase-activating CDC25B phosphatase in human gastric carcinomas
107. Expression of cripto, a novel gene of the epidermal growth factor family, in human gastrointestinal carcinomas
108. Frequent amplification of the c-met gene in scirrhous type stomach cancer
109. Aberrant expression of c-met mRNA in human gastric carcinomas
110. Expression of cripto in human gastric carcinomas: An association with tumor stage and prognosis
111. Frequent loss of heterozygosity of the long arm of chromosome 7 is closely associated with progression of human gastric carcinomas
112. Expression of human telomerase RNA is an early event of stomach carcinogenesis
113. Kip1 in a human gastric carcinoma cell line
114. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer
115. Amplification of cyclin genes in colorectal carcinomas
116. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein
117. hMLHI promoter methylation and lack of hMLHI expression in sporadic gastric carcinomas with high-frequency microsatellite instability
118. Two novel human serine/theonine kinases with monologies to the cell cycle regulating Xenopus MO15, and NIMA kinases: Cloning and characterization of their expression pattern
119. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas
120. Expression of a 31kDa lactoside-binding lectin in normal human gastric mucosa and in primary and metastatic gastric carcinomas
121. The sequential accumulation of genetic alterations characteristic of the colorectal adenomacarcinoma sequence does not occur between gastric adenoma and adenocarcinoma
122. Frameshift mutator mutations
123. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability
124. Involvement of DNA methylation in the control of the expression of an estrogen-induced breast-cancer-associated protein (pS2) in human breast cancers
125. Cloning of cDNA sequences of hormone-regulated genes from MCF-7 human breast cancer cell lines
126. Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities
127. Significance of CD44 gene products for cancer diagnosis and disease evaluation
128. p53 gene mutations in gastric cancer cell lines
129. 5′CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTSI in human cancers
130. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization
131. Cytokines as positive and negative regulators of tumor promotion and progression
132. Gastric carcinoma. A pathological classification
133. Kinetics of nitrosamine formation from alkylureas, N-alkylurethans, and alkylguanidines: Possible implications for the etiology of human gastric cancer
134. Co-expression of heparin-binding EGF-like growth factor and related peptides in human gastric carcinoma
135. + gene occurs in human and is highly expressed in some cancer cells
136. Effect of antisense human telomerase RNA (hTR) transfection on the growth of human gastric cancer cell lines
137. Telomerase catalytic subunit homologs from fission yeast and human
138. Amplified DNA sequences in cancers
139. Detection of amplified DNA sequences in gastric cancers by a DNA renaturation method in gel
140. Isolation of an amplified DNA sequence in stomach cancer
141. Somatic mutation of the APC gene in gastric cancer: Frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma
142. Somatic mutations of the APC gene in precancerous lesion of the stomach
143. Reduced expression of nm23 is asso-ciated with metastasis of human gastric carcinomas
144. TLP1: A gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family
145. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas
146. Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer
147. Alterations of the APC gene in carcinoma cell lines and precancerous lesions of the stomach
148. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients
149. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
150. c-erbB-2 gene product associates with catenins in human cancer cells
151. Frequent loss of alpha catenin expression in scirrhous carcinomas with scattered cell growth
152. p53 mutations in the non-neoplastic mucosa of the human stomach showing intestinal metaplasia
153. DNA ploidy pattern and amplification of ERBB and ERBB2 genes in human gastric carcinomas
154. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers
155. Mutations at coding mononucleotide repeats in gastric cancer with the microsatellite mutator phenotype
156. Mutation of a mutL homolog in hereditary colon cancer
157. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors
158. Frequent somatic mutations of the β-catenen gene in intestinal-type gastric cancer
159. + dependent manner
160. cdc2 on tyrosine 15
161. Cancer and aging in mice and men
162. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest
163. Kip1: Chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors
164. Frequency and spectrum of p53 mutations in gastric cancer - A molecular genetic and immunohistochemical study
165. Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
166. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype
167. Microsatellite instability occurs frequently in human gastric carcinoma
168. The DNA repair gene MBD4 (MEDI) is mutated in human carcinomas with microsatellite instability
169. Germline E-cadherin gene (CDHI) mutations predispose to familial gastric cancer and colorectal cancer
170. cdc28/cdc2-associated protein of Saccharomyces cerevisiae and Schizosaccharomyces pombe
171. Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing
172. Isoforms of the met receptor tyrosine kinase
173. New perspectives in cell adhesion: RGD and integrins
174. Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2
175. Disruption of E-cadherin-mediated cell adhesion systems in gastric cancers in young patients
176. Clinicopathological and molecular biological studies of gastric adenomas with special reference to p53 abnormality
177. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas
178. Silencing of the CD44 gene by CpG methylation in a human gastric carcinoma cell line
179. Cdc25M2 activation of cyclindependent kinases by dephosphorylation of threonine-14 and tyrosine-15
180. Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach
181. Frequent microsatellite instability and loss of heterozygosity in the region including BRCAI (17q21) in young patients with gastric cancer
182. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
183. Sporadic gastric carcinomas with microsatellite instability display a particular clinicopathologic profile
184. Telomerase and telomere-binding proteins: Controlling the endogame
185. G1 phase progression: Cycling on cue
186. Cadherin dysfunction in a human cancer cell line: Possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness
187. Familial gastric cancer: Clinicopathological characteritics, RER phenotype and germiline p53 and E-cadherin mutations
188. Effect of epidermal growth factor on cadherin-mediated adhesion in a human esophageal cancer cell line
189. Mutation of the transforming growth factor-13 type II receptor gene is a rare event in human sporadic gastric carcinomas
190. No mutations of the smad2 gene in human sporadic gastric carcinomas
191. Increased urokinase receptor levels in human gastrointestinal neoplasia and related liver metastases
192. Intestinal metaplasia, atrophic gastritis and stomach cancer: Trends over time
193. TRF1, a mammalian telomeric protein
194. Microsatellite instability in the insulin-like growth factor 11 receptor gene in gastrointestinal tumours
195. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells
196. p53 mutations and microsatellite instability in sporadic gastric cancer: When guardians fail
197. Tumor production in the glandular stomach and alimentary tract of the rat by N-methyl-N′-nitro-N-nitrosoguanidine
198. Distinct methylation pattern and microsatellite instability in sporadic gastric cancer
199. Expression of the E2F family in human gastrointestinal carcinomas
200. Molecular mechanism of stomach carcinogenesis
201. Growth factors in gastric cancer
202. Abnormal expression of growth factors and their receptors in stomach cancer
203. Molecular biological observations in gastric cancer
204. Abnormal growth factor networks in neoplasia
205. Molecular diagnosis of gastrointestinal cancers: The application to clinical practice
206. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions
207. Telomere and telomerase in gastrointestinal cancer
208. Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections
209. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer
210. c-src protein kinase activity in human gastric carcinomas
211. Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis
212. Mutations of the APC gene occur during early stages of gastric adenoma development
213. Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach
214. Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines
215. Expression of CD44R1 adhesion molecule in colon carcinomas and metastases
216. Plasminogen activator inhibitor 1 in human carcinoma tissues
217. Expression of basic fibroblast growth factor in human gastric carcinomas
218. Effect of hepatocyte growth factor (HGF)/scatter factor (SF) on cell adhesion in gastric cancer
219. Expression of the breast cancer associated pS2 and the panceratic spasmolytic polypetide gene (hSP) in diffuse type of stomach carcinoma
220. Microsatellite instability in cancer of the proximal colon
221. p53 gene mutations in gastric adenomas
222. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
223. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype
224. Alterations of oncogenes in metastatic tumours of human gastric carcinomas
225. Frequent loss of heterozygosity at the DCC locus in gastric cancer
226. p53 mutation in gastric cancer: A genetic model for carcinogenesis is common to gastric and colorectal cancer
227. Co-expression of osteopontin and CD44v9 in gastric cancer
228. Interleukin-6: An overview
229. The p21 inhibitor of cyclin-dependent kinase controls DNA replication by interactions with PCNA
230. Origin of concatameric T4 DNA
231. Receptor-ligand interaction between CD44 and osteopontin (Eta-1)
232. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT
233. Trisomy 3 in low grade B cell lymphoma of mucosa associated lymphoid tissue (MALT)
234. Mechanism of activation of the TGF-β receptor
235. p21 is a universal inhibitor of cyclin kinases
236. Expression of vascular endothelial growth factor in human gastric carcinomas
237. Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene
238. Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma
239. Expression of E-cadherin, α- and β-catenins in human gastric carcinomas: Correlation with histology and tumor progression
240. WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: Relation with p53 status and proliferative activity
241. Expression of cyclin E in human gastric adenomas and adenocarcinomas: Correlation with proliferative activity and p53 status
242. CDKN2/MTS1/INK4A in human gastric carcinomas
243. Kip1 is associated with advanced stage and invasivenss of gastric carcinomas
244. Molecular diagnosis of gastrointestinal cancer
245. Expression of telomerase catalytic component, telomerase reverse transcriptase in human gastric carcinomas
246. Immunohistochemical detection of human telomerase reverse transcriptase in normal mucosa and precancerous lesions of the stomach
247. Molecular-pathological diagnosis of gastrointestinal tissues and its contribution to cancer histopathology
248. Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue
249. p53 point mutations in primary human gastric carcinomas
250. Biologic effect of human hepatocyte growth factor on human gastric carcinoma cell lines
251. Expression of CD44 abnormal transcripts in human gastric carcinomas
252. A splice variant of the c-met proto-oncogene is the predominant population expressed in human gastric mucosa and carcinoma
253. Biologic effects of hepatocyte growth factor/scatter factor on the morphogenesis of human gastric carcinoma cell lines
254. Molecular bases of human stomach carcinogenesis
255. Microsatellite instabilities in gastric cancer patients with multiple primary cancers
256. Alterations of p73 gene preferentially occur in gastric adenocarcinomas with foveolar epithelial phenotype
257. Expression of c-erbB-2 oncoprotein in gastric carcinoma. Immunoreactivity for c-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma
258. Germline mutations of E-cadherin gene in Korean familial gastric cancer patients
259. Epidermal growth factor induces the expression of its receptor gene in human gastric carcinoma cell line TMK-1
260. Amplification of epidermal growth factor receptor (EGFR) gene and oncogenes in human gastric carcinomas
261. Expression of TGF-beta and procollagen type I and type III in human gastric carcinomas
262. Induction of growth factor-receptor and metalloproteinase genes by epidermal growth factor and/or transforming growth factor-α in human gastric carcinoma cell lines MKN-28
263. Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors
264. Human HST1 (HSTF1) gene maps to chromosome band 11q13 and coamplifies with the INT2 gene in human cancer
265. Decreased DCC mRNA expression in human gastric cancer is clinicopathologically significant
266. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas
267. Allelotype of gastric adenocarcinoma
268. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck